Chong Kun Dang Pharmaceutical Corp.

# Nodit Nodit is a Web3 development platform specialized in blockchain data. Nodit aims to provide enterprise-grade multi-chain Web3 infrastructure accessible to everyone. By offering reliable node infrastructure with 99.9% uptime and consistent ready-to-query blockchain data at an affordable price, we are facilitating developers’ entry into the Web3 world. # Lambda256 Lambda256, the blockchain tech arm of Dunamu, developed and operates Nodit, which enhances efficiency in managing tasks like blockchain network setup, node operation, and data processing for Ethereum, Arbitrum, and Aptos and Luniverse, a cloud-based blockchain infrastructure platform. Lambda256 also offers a travel rule solution to meet FATF guidelines, improving security and compliance for virtual asset transactions. The company secured Series A funding, followed by Series B funding in December 2021, achieving a total accumulated investment of approximately +80 million USD.

BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators: Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology.